866-997-4948(US-Canada Toll Free)

Neurology Devices Market Outlook in United States to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Published By :

GlobalData

Published Date : Sep 2010

Category :

Neurology Devices

No. of Pages : 194 Pages


GlobalDatas medical device report, Neurology Devices Market Outlook in the US to 2016 Neurostimulation Devices, Interventional Neurology and Others provides key market data on the US Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology, and Radiosurgery. Segments include Hydrocephalus Shunts, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Embolic Systems, Navigational Systems, CyberKnife Radiosurgery and Others.The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Market size and company share data for Neurology Devices market categories CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology, and Radiosurgery
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. Segments include Hydrocephalus Shunts, Vagus Nerve Stimulators, Spinal Cord Stimulators, Deep Brain Stimulators, Embolic Systems, Navigational Systems, CyberKnife Radiosurgery and Others.
  • 2009 company shares and distribution shares data for each of the five market categories.
  • Global corporate-level profiles of key companies operating within the US Neurology Devices market.
  • Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Cordis Corporation, Cyberonics, Inc. and others.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Explore investment opportunites in the market.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table Of Content

1 Table of Contents
1.1 List of Tables 
1.2 List of Figures 

2 Introduction
2.1 What is This Report About? 

3 Neurology Devices In United States
3.1 Neurology Devices, Market Segmentation 
3.2 Neurology Devices, United States, Overall Revenue ($m), 2002-2016 
3.3 Neurology Devices Market, United States, Revenue Mix ($m), 2009 
3.4 Neurology Devices Market, United States, Category Contribution (%), 2009 
3.5 Neurology Devices, United States, Category Volume (Units), 2002-2016 
3.6 Neurology Devices, United States, Company Share (2008-2009) 

4 CSF Management In United States
4.1 CSF Management, Market Segmentation 
4.2 CSF Management Market, United States, Revenue Mix ($m), 2009 
4.3 CSF Management Market, United States, Segment Contribution (%), 2009 
4.4 CSF Management Overall Revenue (2002-2016) 
4.5 CSF Management Overall Volume (2002-2016) 
4.6 CSF Management Average Price (2002-2016) 
4.7 CSF Management Distribution Share (2008-2009) 
4.8 CSF Management, United States, Company Share (2008-2009) 

5 Interventional Neurology In United States
5.1 Interventional Neurology, Market Segmentation 
5.2 Interventional Neurology Market, United States, Revenue Mix ($m), 2009 
5.3 Interventional Neurology Market, United States, Segment Contribution (%), 2009 
5.4 Interventional Neurology Overall Revenue (2002-2016) 
5.4.1 Embolic Systems Revenue (2002-2016) 
5.4.2 Navigational Systems Revenue (2002-2016) 
5.5 Interventional Neurology Overall Volume (2002-2016)
5.5.1 Embolic Systems Volume (2002-2016) 
5.5.2 Navigational Systems Volume (2002-2016) 
5.6 Interventional Neurology Average Price (2002-2016)
5.7 Interventional Neurology Distribution Share (2008-2009) 
5.8 Interventional Neurology, United States, Company Share (2008-2009) 

6 Neurostimulation Devices In United States
6.1 Neurostimulation Devices, Market Segmentation 
6.2 Neurostimulation Devices Market, United States, Revenue Mix ($m), 2009 
6.3 Neurostimulation Devices Market, United States, Segment Contribution (%), 2009 
6.4 Neurostimulation Devices Overall Revenue (2002-2016) 
6.5 Neurostimulation Devices Overall Volume (2002-2016) 
6.6 Neurostimulation Devices Average Price (2002-2016) 
6.7 Neurostimulation Devices Distribution Share (2008-2009) 
6.8 Neurostimulation Devices, United States, Company Share (2008-2009) 

7 Neurosurgical Products In United States
7.1 Neurosurgical Products Overall Revenue (2002-2016) 
7.2 Neurosurgical Products Overall Volume (2002-2016) 
7.3 Neurosurgical Products Average Price (2002-2016) 
7.4 Neurosurgical Products Distribution Share (2008-2009) 
7.5 Neurosurgical Products, United States, Company Share (2008-2009) 

8 Radiosurgery In United States
8.1 Radiosurgery, Market Segmentation 
8.2 Radiosurgery Market, United States, Revenue Mix ($m), 2009 
8.3 Radiosurgery Market, United States, Segment Contribution (%), 2009 
8.4 Radiosurgery Overall Revenue (2002-2016) 
8.5 Radiosurgery Overall Volume (2002-2016) 
8.6 Radiosurgery Average Price (2002-2016) 
8.7 Radiosurgery Distribution Share (2008-2009) 
8.8 Radiosurgery, United States, Company Share (2008-2009) 

9 Overview of Key Companies in United States Neurology Devices Market
9.1 Medtronic, Inc. 
9.1.1 Company Overview 
9.1.2 Share in the United States Neurology Devices Market 
9.2 Boston Scientific Corporation
9.2.1 Company Overview 
9.2.2 Share in the United States Neurology Devices Market 
9.3 St. Jude Medical, Inc.
9.3.1 Company Overview 
9.3.2 Share in the United States Neurology Devices Market 
9.4 Cyberonics, Inc.
9.4.1 Company Overview 
9.4.2 Share in the United States Neurology Devices Market 
9.5 Cordis Corporation
9.5.1 Company Overview 
9.5.2 Share in the United States Neurology Devices Market 
9.6 Accuray Incorporated
9.6.1 Company Overview 
9.6.2 Share in the United States Neurology Devices Market 
9.7 Elekta AB
9.7.1 Company Overview 
9.7.2 Share in the United States Neurology Devices Market 
9.8 ev3 Inc.
9.8.1 Company Overview 
9.8.2 Share in the United States Neurology Devices Market 
9.9 Micrus Endovascular Corporation
9.9.1 Company Overview 
9.9.2 Share in the United States Neurology Devices Market 
9.10 Codman & Shurtleff, Inc.
9.10.1 Company Overview 
9.11 Integra LifeSciences Holdings Corporation
9.11.1 Company Overview 
9.12 B. Braun Melsungen AG
9.12.1 Company Overview 
9.13 Terumo Corporation
9.13.1 Company Overview 
9.14 KARL STORZ GmbH & Co. KG
9.14.1 Company Overview 

10 Neurology Devices Market Pipeline Products

11 Financial Deals Landscape
11.1 Acquisition 
11.1.1 HealthMed Services to Acquire Neural Communicator 
11.1.2 Masimo Completes Acquisition of SEDLine 
11.1.3 Johnson & Johnson To Acquire Micrus Endovascular For $480 Million 
11.1.4 Covidien Completes Acquisition Of ev3 For $2.6 Billion 
11.1.5 SEDLine Receives Investment Of $3.5 Million From Masimo 
11.1.6 CareFusion Receives Tender Offer For Acquisition From TRC Capital 
11.1.7 Sonova Holding Acquires Advanced Bionics 
11.1.8 SANUWAVE Completes Reverse Acquisition With Rub Music Enterprises 
11.1.9 Natus Medical Acquires Alpine Biomed 

12 Recent Developments
12.1 Strategy and Business Planning 
12.1.1 Aug 26, 2010: Pico-Tesla Opens New Facility in Michigan 
12.1.2 Aug 24, 2010: Cyberonics Signs Epilepsy Technology Agreements With NeuroVista In Field Of EEG-based Seizure Detection 
12.1.3 Aug 20, 2010: Integra Opens Center For Research, Education And Training In Irvine, California 
12.1.4 Aug 19, 2010: Boston Scientific To Invest In New Products: CEO 
12.1.5 Aug 10, 2010: CareFusion Announces Company-Wide Restructuring 
12.1.6 Jun 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany 
12.1.7 May 06, 2010: Swedish Cancer Institute And Elekta Renew Partnership Agreement 
12.1.8 Apr 20, 2010: Siemens Opens National Customer Service Headquarters For 24x7 Service And Support 
12.1.9 Mar 17, 2010: EnteroMedics Extends Collaboration Agreement With Mayo Clinic For Two Years 
12.1.10 Mar 15, 2010: Pico-Tesla Opens Florida Office 
12.1.11 Feb 24, 2010: Zynex Announces Development Of Two New Business Units 
12.1.12 Feb 17, 2010: Greatbatch Medical Opens New Orthopaedic Design Center In Warsaw, Indiana 
12.1.13 Feb 11, 2010: St. Jude Medical Expands In Austin, Texas 
12.1.14 Nov 24, 2009: Paragon Innovations To Shift Its Headquarters To Richardson, Texas 
12.1.15 Oct 21, 2009: Accuray Announces Regionalized Management Strategy For Americas 
12.2 Legal and Regulatory
12.2.1 Aug 10, 2010: Best Medical Files Patent Infringement Lawsuit against Accuray 
12.2.2 Jul 12, 2010: Law Offices Of Howard G. Smith Investigates Micrus Acquisition For Shareholders 
12.2.3 Jul 06, 2010: ev3 Agrees To Settle Stockholder Litigation 
12.2.4 Jun 01, 2010: Finkelstein Thompson LLP Announces Investigation Of ev3 
12.2.5 Apr 09, 2010: Robbins Geller Files Class Action Suit Against Boston Scientific 
12.2.6 Mar 18, 2010: Coughlin Stoia Files Class Action Suit Against St. Jude Medical 
12.2.7 Feb 23, 2010: Astro-Med Wins $1.5 Million Employee Non-Compete Agreement Suit 
12.2.8 Jan 11, 2010: Holzer Holzer & Fistel Is Investigating Potential Violations Of Federal Securities Laws By St. Jude Medical 
12.2.9 Dec 14, 2009: NeuroMetrix Reports Dismissal Of Securities Class Action Lawsuit 
12.2.10 Dec 14, 2009: NeuroMetrix Announces Dismissal Of Securities Class Action Lawsuit 
12.2.11 Sep 24, 2009: Synergetics Announces Stay Of Alcon Patent And Trademark Infringement Lawsuit 
12.3 Government and Public Interest
12.3.1 Aug 25, 2010: Research Heralds Potential For Early Diagnosis Of Degenerative Brain Disorders 
12.3.2 Aug 22, 2010: Gene Scan Finds Link Across Array Of Childhood Brain Disorders 
12.3.3 Aug 11, 2010: Boston Scientific Resolves Corporate Warning Letter 
12.3.4 Jul 22, 2010: Stanford University School Of Medicine Seeks Patient Enrollment For Alzheimer's Study 
12.3.5 Jul 12, 2010: MRI Better Than CT Scans At Diagnosing Stroke: New Guideline 
12.3.6 Jun 30, 2010: New Study Identifies Best Tests For Predicting Alzheimer’s Disease: Study 
12.3.7 Jun 22, 2010: UCLA Brain Scanning Study Has Implications For Advertising, Public Health Campaigns 
12.3.8 Jun 03, 2010: Governor Designates Cleveland Health And Technology Corridor An Ohio Hub Of Innovation And Opportunity 
12.3.9 May 11, 2010: Stereotactic Radiosurgery Is Safe And Effective For Selected Children With Arteriovenous Malformations: Mayo Clinic 
12.3.10 May 04, 2010: Stereotactic Radiosurgery Successful For Most Patients With Large Acoustic Neuromas: Mayo Clinic 
12.3.11 May 03, 2010: Imaging Study Discovers Brain Development Differences In Kids With Fragile X Syndrome: Study 
12.3.12 Apr 30, 2010: Tiny Particles May Help Surgeons By Marking Brain Tumors 
12.3.13 Apr 19, 2010: Surgeons Use Brain Port Device To Treat Brain Cyst 
12.3.14 Apr 18, 2010: Scientists Develop Brain-Recording Device To Control Seizures 
12.3.15 Apr 16, 2010: Clinical Study Shows Patients Gain Limb Movement Years After Stroke 
12.3.16 Apr 09, 2010: CDRH: Research Needed To Explore Side Effects Of Pediatric Devices 
12.3.17 Apr 01, 2010: UC Researchers Quantify Benefits Of Minimally Invasive Removal For Tumors 
12.3.18 Mar 22, 2010: Scans Of Brain Networks May Help Predict Injury's Effects 
12.3.19 Mar 15, 2010: Study: Mechanomyography To Be Accurate In Detecting Nerves 
12.3.20 Mar 04, 2010: Brain Scans Could Be Marketing Tool Of The Future 
12.3.21 Mar 02, 2010: Scientists Redesigns 3-D Hand Movement Using Brain Signals 
12.3.22 Feb 09, 2010: Neuroimaging Study May Pave Way For Effective Alzheimer’s Treatments 
12.3.23 Feb 01, 2010: FDA Approves Novel Study Of Neurostimulation As Treatment For Heart Disease 
12.3.24 Jan 05, 2010: Congress Allocates $1.6 Million To Worcester Polytechnic Institute For Research On Advanced Neuroprosthetics 
12.3.25 Dec 30, 2009: Guideline: Widely Used Device For Pain Therapy Not Recommended For Chronic Low-Back Pain 
12.3.26 Dec 23, 2009: APA Urges Reclassification Of Electroconvulsive Therapy By FDA In Order To Maintain Availability 
12.3.27 Nov 17, 2009: Investigational Neurostimulation Device Aims To Reduce Stroke Damage 
12.3.28 Nov 17, 2009: DEP Fines Valley Advanced Gamma Knife For Abandoning Radioactive Equipment, Violating Radiation Protection Act 
12.3.29 Nov 11, 2009: Imaging Study Shows Brain Abnormalities In Chemotherapy Patients 
12.3.30 Oct 20, 2009: Boston Scientific Warns Against $4 Billion Medical Device Tax 
12.3.31 Oct 08, 2009: Radiation Costs Vary Widely By Delivery, U-M Study Finds 
12.3.32 Sep 29, 2009: A Step Toward Better Brain Implants Using Conducting Polymer Nanotubes 
12.4 Product News
12.4.1 Aug 10, 2010: NKI To Present Two Research Studies On I-Portal NOTC System At Barany Society Conference 
12.4.2 Jul 15, 2010: Elekta To Highlight Intelligent Cancer Management Solutions At 2010 AAPM Annual Meeting 
12.4.3 May 05, 2010: Terumo Announces Its Program For The Global Embolization Symposium And Technologies (GEST) Meeting 
12.4.4 Mar 09, 2010: MIT Selects Elekta Neuromag To Explore Brain Function 
12.4.5 Mar 01, 2010: Integra Launches OSV II Lumbar And OSV II Low Flow Lumbar Self-Adjusting Valves 
12.4.6 Feb 23, 2010: Barnes-Jewish Hospital Treats More Patients With Elekta’s Extend Program For Gamma Knife Perfexion 
12.4.7 Dec 23, 2009: Neuronetics To Complete Johns Hopkins University Phase II Study For NeuroStar TMS Therapy System In Second Half Of 2011 
12.4.8 Dec 21, 2009: CyberKnife Institute To Treat Its Inoperable Tumors Patients With 
CyberKnife Robotic Radiosurgery System 

13 Appendix
13.1 Definitions of Markets Covered in the Report 
13.1.1 Neurology Devices 
13.2 Research Methodology
13.3 Secondary Research 
13.4 Primary Research 
13.5 Models 
13.6 Forecasts 
13.7 Expert Panels 
13.8 GlobalData Consulting 
13.9 Contact Us 
13.10 Disclaimer 

List of Table


Table 1: Neurology Devices, United States, Overall Revenue ($m), 2002-2016 16
Table 2: Neurology Devices Market, United States, Category Contribution (%), 2009 18
Table 3: Neurology Devices, United States, Cross-Category Analysis, 2002-2016 19
Table 4: Neurology Devices, United States, Overall Revenue ($m), Historic, 2002-2009 21
Table 5: Neurology Devices, United States, Overall Revenue ($m), Forecast, 2009-2016 23
Table 6: Neurology Devices, United States, Category Volume (Units), 2002-2016 24
Table 7: Neurology Devices, United States, Category Volume (Units), Historic, 2002-2009 26
Table 8: Neurology Devices, United States, Category Volume (Units), Forecast, 2009-2016 28
Table 9: Neurology Devices, United States, Company Share by Revenue ($m), 2008-2009 30
Table 10: CSF Management Market, United States, Segment Contribution (%), 2009 33
Table 11: CSF Management, United States, Revenue ($m) by Segment, Historic, 2002-2009 35
Table 12: CSF Management, United States, Revenue ($m) by Segment, Forecast, 2009-2016 37
Table 13: CSF Management, United States, Volume (Units) by Segment, Historic, 2002-2009 39
Table 14: CSF Management, United States, Volume (Units) by Segment, Forecast, 2009-2016 41
Table 15: CSF Management, United States, Average Price ($), Historic, 2002-2009 42
Table 16: CSF Management, United States, Average Price ($), Forecast, 2009-2016 42
Table 17: CSF Management, United States, Distribution Share by Revenue ($m), 2008-2009 43
Table 18: CSF Management, United States, Company Share by Revenue ($m), 2008-2009 45
Table 19: Interventional Neurology Market, United States, Segment Contribution (%), 2009 48
Table 20: Interventional Neurology, United States, Revenue ($m) by Segment, Historic, 2002-2009 50
Table 21: Interventional Neurology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 52
Table 22: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 54
Table 23: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 56
Table 24: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 58
Table 25: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 60
Table 26: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2002-2009 62
Table 27: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2009-2016 64
Table 28: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 66
Table 29: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 68
Table 30: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 70
Table 31: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 72
Table 32: Interventional Neurology, United States, Average Price ($), Historic, 2002-2009 73
Table 33: Interventional Neurology, United States, Average Price ($), Forecast, 2009-2016 73
Table 34: Interventional Neurology, United States, Distribution Share by Revenue ($m), 2008-2009 74
Table 35: Interventional Neurology, United States, Company Share by Revenue ($m), 2008-2009 76
Table 36: Neurostimulation Devices Market, United States, Segment Contribution (%), 2009 79
Table 37: Neurostimulation Devices, United States, Revenue ($m) by Segment, Historic, 2002-2009 81
Table 38: Neurostimulation Devices, United States, Revenue ($m) by Segment, Forecast, 2009-2016 83
Table 39: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2002-2009 85
Table 40: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2009-2016 87
Table 41: Neurostimulation Devices, United States, Average Price ($), Historic, 2002-2009 88
Table 42: Neurostimulation Devices, United States, Average Price ($), Forecast, 2009-2016 88
Table 43: Neurostimulation Devices, United States, Distribution Share by Revenue ($m), 2008-2009 89
Table 44: Neurostimulation Devices, United States, Company Share by Revenue ($m), 2008-2009 91
Table 45: Neurosurgical Products, United States, Revenue ($m), Historic, 2002-2009 92
Table 46: Neurosurgical Products, United States, Revenue ($m), Forecast, 2009-2016 93
Table 47: Neurosurgical Products, United States, Volume (Units), Historic, 2002-2009 94
Table 48: Neurosurgical Products, United States, Volume (Units), Forecast, 2009-2016 95
Table 49: Neurosurgical Products, United States, Average Price ($), Historic, 2002-2009 96
Table 50: Neurosurgical Products, United States, Average Price ($), Forecast, 2009-2016 96
Table 51: Neurosurgical Products, United States, Distribution Share by Revenue ($m), 2008-2009 97
Table 52: Neurosurgical Products, United States, Company Share by Revenue ($m), 2008-2009 98
Table 53: Radiosurgery Market, United States, Segment Contribution (%), 2009 101
Table 54: Radiosurgery, United States, Revenue ($m) by Segment, Historic, 2002-2009 103
Table 55: Radiosurgery, United States, Revenue ($m) by Segment, Forecast, 2009-2016 105
Table 56: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2002-2009 107
Table 57: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2009-2016 109
Table 58: Radiosurgery, United States, Average Price ($), Historic, 2002-2009 110
Table 59: Radiosurgery, United States, Average Price ($), Forecast, 2009-2016 110
Table 60: Radiosurgery, United States, Distribution Share by Revenue ($m), 2008-2009 111
Table 61: Radiosurgery, United States, Company Share by Revenue ($m), 2008-2009 112
Table 62: Neurology Devices Market Pipeline Products 125
Table 63: HealthMed Services To Acquire Neural Communicator 129
Table 64: Masimo Completes Acquisition Of SEDLine 130
Table 65: Johnson & Johnson To Acquire Micrus Endovascular For $480 Million 131
Table 66: Covidien Completes Acquisition Of ev3 For $2.6 Billion 133
Table 67: SEDLine Receives Investment Of $3.5 Million From Masimo 135
Table 68: CareFusion Receives Tender Offer For Acquisition From TRC Capital 136
Table 69: Sonova Holding Acquires Advanced Bionics 137
Table 70: SANUWAVE Completes Reverse Acquisition With Rub Music Enterprises 139
Table 71: Natus Medical Acquires Alpine Biomed 141

List of Chart


Figure 1: Neurology Devices, Market Segmentation 14
Figure 2: Neurology Devices, United States, Overall Revenue ($m), 2002-2016 15
Figure 3: Neurology Devices Market, United States, Revenue Mix ($m), 2009 17
Figure 4: Neurology Devices Market, United States, Category Contribution (%), 2009 18
Figure 5: Neurology Devices, United States, Cross-Category Analysis, 2002-2016 19
Figure 6: Neurology Devices, United States, Overall Revenue ($m), Historic, 2002-2009 20
Figure 7: Neurology Devices, United States, Overall Revenue ($m), Forecast, 2009-2016 22
Figure 8: Neurology Devices, United States, Category Volume (Units), 2002-2016 24
Figure 9: Neurology Devices, United States, Category Volume (Units), Historic, 2002-2009 25
Figure 10: Neurology Devices, United States, Category Volume (Units), Forecast, 2009-2016 27
Figure 11: Neurology Devices, United States, Company Share (%), 2009 29
Figure 12: CSF Management, Market Segmentation 31
Figure 13: CSF Management Market, United States, Revenue Mix ($m), 2009 32
Figure 14: CSF Management Market, United States, Segment Contribution (%), 2009 33
Figure 15: CSF Management, United States, Revenue ($m) by Segment, Historic, 2002-2009 34
Figure 16: CSF Management, United States, Revenue ($m) by Segment, Forecast, 2009-2016 36
Figure 17: CSF Management, United States, Volume (Units) by Segment, Historic, 2002-2009 38
Figure 18: CSF Management, United States, Volume (Units) by Segment, Forecast, 2009-2016 40
Figure 19: CSF Management, United States, Company Share (%), 2009 44
Figure 20: Interventional Neurology, Market Segmentation 46
Figure 21: Interventional Neurology Market, United States, Revenue Mix ($m), 2009 47
Figure 22: Interventional Neurology Market, United States, Segment Contribution (%), 2009 48
Figure 23: Interventional Neurology, United States, Revenue ($m) by Segment, Historic, 2002-2009 49
Figure 24: Interventional Neurology, United States, Revenue ($m) by Segment, Forecast, 2009-2016 51
Figure 25: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 53
Figure 26: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 55
Figure 27: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009 57
Figure 28: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 59
Figure 29: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2002-2009 61
Figure 30: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2009-2016 63
Figure 31: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 65
Figure 32: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 67
Figure 33: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2002-2009 69
Figure 34: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2009-2016 71
Figure 35: Interventional Neurology, United States, Company Share (%), 2009 75
Figure 36: Neurostimulation Devices, Market Segmentation 77
Figure 37: Neurostimulation Devices Market, United States, Revenue Mix ($m), 2009 78
Figure 38: Neurostimulation Devices Market, United States, Segment Contribution (%), 2009 79
Figure 39: Neurostimulation Devices, United States, Revenue ($m) by Segment, Historic, 2002-2009 80
Figure 40: Neurostimulation Devices, United States, Revenue ($m) by Segment, Forecast, 2009-2016 82
Figure 41: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2002-2009 84
Figure 42: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2009-2016 86
Figure 43: Neurostimulation Devices, United States, Company Share (%), 2009 90
Figure 44: Neurosurgical Products, United States, Revenue ($m), Historic, 2002-2009 92
Figure 45: Neurosurgical Products, United States, Revenue ($m), Forecast, 2009-2016 93
Figure 46: Neurosurgical Products, United States, Volume (Units), Historic, 2002-2009 94
Figure 47: Neurosurgical Products, United States, Volume (Units), Forecast, 2009-2016 95
Figure 48: Neurosurgical Products, United States, Company Share (%), 2009 98
Figure 49: Radiosurgery, Market Segmentation 99
Figure 50: Radiosurgery Market, United States, Revenue Mix ($m), 2009 100
Figure 51: Radiosurgery Market, United States, Segment Contribution (%), 2009 101
Figure 52: Radiosurgery, United States, Revenue ($m) by Segment, Historic, 2002-2009 102
Figure 53: Radiosurgery, United States, Revenue ($m) by Segment, Forecast, 2009-2016 104
Figure 54: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2002-2009 106
Figure 55: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2009-2016 108
Figure 56: Radiosurgery, United States, Company Share (%), 2009 112
Figure 57: Medtronic, Inc., Company Share (%),United States Neurology Devices Market, 2009 113
Figure 58: Boston Scientific Corporation, Company Share (%),United States Neurology Devices Market, 2009 115
Figure 59: St. Jude Medical, Inc., Company Share (%),United States Neurology Devices Market, 2009 116
Figure 60: Cyberonics, Inc., Company Share (%),United States Neurology Devices Market, 2009 117
Figure 61: Cordis Corporation, Company Share (%),United States Neurology Devices Market, 2009 118
Figure 62: Accuray Incorporated, Company Share (%),United States Neurology Devices Market, 2009 119
Figure 63: Elekta AB, Company Share (%),United States Neurology Devices Market, 2009 120
Figure 64: ev3 Inc., Company Share (%),United States Neurology Devices Market, 2009 121
Figure 65: Micrus Endovascular Corporation, Company Share (%),United States Neurology Devices Market, 2009 122

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *